March 22 (Reuters) - China’s CanSino Biologics Inc said on Monday its COVID-19 vaccine has been granted authorisation for emergency use in Hungary.
The Hungarian National Institute of Pharmacy and Nutrition granted the approval for its vaccine, with trade name Convidecia, based on the interim results of its phase III trial, the company said in a statement. (Reporting by Rashmi Ashok in Bengaluru; Editing by Christopher Cushing)
Our Standards: The Thomson Reuters Trust Principles.